Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.10 USD
Change Today +0.50 / 4.72%
Volume 6.6K
PMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 5:20 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

psychemedics corp (PMD) Key Developments

Psychemedics Corporation Adopts the Amended and Restated Bylaws

On July 28, 2015, the Board of Directors of Psychemedics Corporation adopted the Psychemedics Corporation Amended and Restated Bylaws to implement additional informational and other procedures for stockholder nominations and proposals in order to enable the Board to better analyze, evaluate and make recommendations to the company's stockholders with respect to such nominations and proposals and to increase the information available to stockholders if nominations and proposals are submitted for stockholder approval, and to clarify certain items. The Amended and Restated Bylaws include certain provisions that are consistent with current custom and practice, and differ from and clarify certain items in the company's previous bylaws.

Psychemedics Corp. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Psychemedics Corp. announced unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, revenues were $7,001,409 against $7,694,137 a year ago. Operating income was $356,046 against $1,319,708 a year ago. Net income before provision for income taxes was $325,169 against $1,322,943 a year ago. Net income and comprehensive income was $252,329 against $856,919 a year ago. Basic and diluted net income per share was $0.05 against $0.16 a year ago. For the six months, revenues were $13,757,150 against $14,738,958 a year ago. Operating income was $806,561 against $2,487,760 a year ago. Net income before provision for income taxes was $742,357 against $2,492,544 a year ago. Net income and comprehensive income was $529,851 against $1,613,078 a year ago. Basic and diluted net income per share was $0.10 against $0.30 a year ago.

Psychemedics Corporation Announces a Quarterly Dividend, Payable on August 18, 2015

Psychemedics Corporation announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2015 to be paid on August 18, 2015.

Psychemedics Corp. to Report Q2, 2015 Results on Jul 28, 2015

Psychemedics Corp. announced that they will report Q2, 2015 results After-Market on Jul 28, 2015

Psychemedics Corp. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Psychemedics Corp. reported unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net income of $277,522, or $0.05 per basic and diluted share; down from $756,159, or $0.14 per basic and diluted share in the last year. Revenues were $6,755,741 compared to $7,044,821 a year ago. Operating income was $450,515 compared to $1,168,052 a year ago. Net income before provision for income taxes was $417,188 compared to $1,169,601 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMD:US $11.10 USD +0.50

PMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $14.35 USD +0.75
Enzo Biochem Inc $2.87 USD +0.03
Genomic Health Inc $27.75 USD +1.02
NeoGenomics Inc $6.28 USD +0.30
RadNet Inc $6.04 USD -0.17
View Industry Companies
 

Industry Analysis

PMD

Industry Average

Valuation PMD Industry Range
Price/Earnings 26.9x
Price/Sales 2.0x
Price/Book 4.8x
Price/Cash Flow 27.1x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSYCHEMEDICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.